ORKA: HC Wainwright Reiterates Buy
HC Wainwright & Co. reiterates buy rating on Oruka Therapeutics and maintains $120 price target
HC Wainwright & Co.
Reiterates Buy on Oruka Therapeutics, Maintains $120 Price Target
HC Wainwright & Co. reiterates buy rating on Oruka Therapeutics and maintains $120 price target
HC Wainwright & Co.
Reiterates Buy on Oruka Therapeutics, Maintains $120 Price Target